alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and org 26576

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with org 26576 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banasr, M; Duman, RS; Henry, B; Koo, JW; Li, XY; Shahid, M; Su, XW1
Brand, L; Hamlyn, E; Harvey, BH; Shahid, M1
Bursi, R; Campbell, R; Dogterom, P; Erdemli, G; Hutmacher, MM; Jeggo, R; Kerbusch, T; Nations, KR; Schipper, J; Shahid, M; Spanswick, D1
Jardemark, K; Malmerfelt, A; Marcus, MM; Shahid, M; Svensson, TH1
Calabrese, F; Fumagalli, F; Luoni, A; Racagni, G; Riva, MA; Shahid, M1
Adler, LA; Cazorla, P; Kroon, RA; Schipper, J; Shahid, M; Stein, M; Szegedi, A; Tarazi, FI1
Bursi, R; Dogterom, P; Ereshefsky, L; Gertsik, L; Mant, T; Nations, KR; Schipper, J1
Bursi, R; Dogterom, P; Ereshefsky, L; Gertsik, L; Greenwald, S; Johnstone, J; Lee, A; Nations, KR; Pande, Y; Ruigt, G; Schipper, J; Zraket, D1

Trials

4 trial(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and org 26576

ArticleYear
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576.
    Psychopharmacology, 2011, Volume: 218, Issue:4

    Topics: Allosteric Regulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Computer Simulation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Translational Research, Biomedical

2011
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
    Biological psychiatry, 2012, Dec-01, Volume: 72, Issue:11

    Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Treatment Outcome

2012
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
    Drugs in R&D, 2012, Sep-01, Volume: 12, Issue:3

    Topics: Adolescent; Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Receptors, AMPA; Young Adult

2012
Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:12

    Topics: Adult; Allosteric Regulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Human Growth Hormone; Humans; Hydrocortisone; Male; Maximum Tolerated Dose; Middle Aged; Psychiatric Status Rating Scales; Receptors, AMPA; Severity of Illness Index; Treatment Outcome; Young Adult

2012

Other Studies

4 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and org 26576

ArticleYear
Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus.
    Psychopharmacology, 2009, Volume: 206, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antidepressive Agents; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors

2009
The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats.
    Behavioural pharmacology, 2009, Volume: 20, Issue:7

    Topics: Allosteric Regulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Spatial Behavior

2009
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
    Psychopharmacology, 2012, Volume: 221, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Drug Synergism; Glutamic Acid; Glycine Plasma Membrane Transport Proteins; Haloperidol; Male; Membrane Potentials; Olanzapine; Oxadiazoles; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Synaptic Transmission; Tetrahydronaphthalenes

2012
The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus.
    Pharmacological research, 2012, Volume: 65, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain-Derived Neurotrophic Factor; Exons; Hippocampus; Male; Neuronal Plasticity; Phosphorylation; Prefrontal Cortex; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Stress, Psychological; Swimming; Transcription, Genetic

2012